Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is 23andMe a Buy Before Its SPAC Merger Is Done?

TheMotleyFool

0 0

Is 23andMe a Buy Before Its SPAC Merger Is Done?

23andMe, the genetics company best known for its in-home DNA testing kits, is set to go public through a merger with special-purpose acquisition company (SPAC) VG Acquisition (NYSE: VGAC). In this Fool Live video clip, recorded on March 15, Fool.com contributor Matt Frankel, CFP, and Industry Focus host Jason Moser discuss why the company has so much long-term potential and why investors might want to take a closer look.

Source Fool.com

Like: 0

VGAC

Share